C vs REGN · P/E 16, rev $85.22B vs P/E 14, rev $14.34B
Citigroup Inc. (C) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
C currently screens at market cap $214.73B and trailing P/E 15.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the C and REGN stock pages for the full models.
Not investment advice.